Sign up to save your podcasts
Or
Share In conversation with...
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
In conversation with...
In conversation with... episodes
- Inhaled budesonide in the treatment of early COVID-19
Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltext11 min - Tocilizumab and COVID-19
Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext6 min - Interferon treatment and COVID-19
Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566-X/fulltext7 min - Evaluating deterioration in patients with acute COVID-19
Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext9 min - Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30458-6/fulltext16 min - COVID-19 and severe influenza
Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ.
9 min - The second wave and homeless populations
Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.
8 min - Corticosteroids, COPD, asthma and COVID-19
Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19
10 min - Novel strategies to drive down the global burden of asthma
Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.
12 min - The pathology of suspected EVALI
Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.
13 min
About In conversation with...
From the publisher's feed
Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.